Low molecular heparins for acute therapy of venous thromboembolism

VADT study: again no benefit with strict glucose control in type 2 diabetes mellitus

ACCOMPLISH study: first endpoint study for starting treatment of hypertension with a combination therapy

Federal Joint Committee asks for reevaluation of HPV vaccination

Olanzapin (ZYPREXA): generics have to go off market

Stroke due to intravitreal bevacizumab (AVASTIN)

Necrosis of the jaw due to alendronate (FOSAMAX, generics)

Fentanyl lollipops ACTIQ: fatal mix-up